News & Events
-
April 1, 2014
Progress in Tuberculosis Vaccine Development and Host-Directed Therapies–a State of the Art Review
Kaufmann SHE, Lange C, Rao M, Balaji KN, Lotze M, Schito M, Zumla AI, Maeurer M. Progress in Tuberculosis Vaccine Development and Host-Directed Therapies–a State of the Art Review. The Lancet Respiratory Medicine. 2014 Apr;2(4):301–20.
-
April 1, 2014
New Antituberculosis Drugs, Regimens, and Adjunct Therapies: Needs, Advances, and Future Prospects
Zumla AI, Gillespie SH, Hoelscher M, Philips PPJ, Cole ST, Abubakar I, McHugh TD, Schito M, Maeurer M, Nunn AJ. New Antituberculosis Drugs, Regimens, and Adjunct Therapies: Needs, Advances, and Future Prospects. The Lancet Infectious Diseases. 2014 Apr;14(4):327–40.
-
April 1, 2014
Totally-Drug-Resistant Tuberculosis: Hype versus Hope
Maeurer M, Schito M, Zumla A. Totally-Drug-Resistant Tuberculosis: Hype versus Hope. The Lancet Respiratory Medicine. 2014 Apr;2(4):256–7.
-
April 1, 2014
Advancing the Portfolio of Tuberculosis Diagnostics, Drugs, Biomarkers, and Vaccines
Zumla AI, Schito M, Maeurer M. Advancing the Portfolio of Tuberculosis Diagnostics, Drugs, Biomarkers, and Vaccines. The Lancet Infectious Diseases. 2014 Apr;14(4):267–9.
-
June 1, 2013
Drug-Resistant Tuberculosis: Time for Visionary Political Leadership
Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I, Ford N, Cox H, Lawn SD, Marais BJ, McHugh TD, Mwaba P, Bates M, Lipman M, Zijenah L, Logan S, McNerney R, Zumla A, Sarda K, Nahid P, Hoelscher M, Pletschette M, Memish ZA, Kim P, Hafner R, Cole S, Migliori GB, Maeurer M, Schito M, Zumla A. Drug-Resistant Tuberculosis: Time for Visionary Political Leadership. The Lancet Infectious Diseases. 2013 Jun;13(6):529–39.